神経治療学
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
特集 神経疾患治療の進歩 2017
末梢神経疾患の治療の進歩
桑原 聡
著者情報
ジャーナル フリー

2018 年 35 巻 5 号 p. 617-619

詳細
抄録

Various clinical trials for peripheral neuropathy were published in 2017. Systematic PubMed search using terms, “neuropathy”, “peripheral neuropathy”, “treatment”, “therapy”, and “clinical trials” was performed with the time lock from January 1, 2017 through December 31, 2017. Twenty–four clinical trials were detected on diabetic neuropathy (DPN), chemotherapy–induced peripheral neuropathy (CIPN), hereditary ATTR amyloidosis, POEMS syndrome, Guillain–Barre syndrome (GBS), and chronic inflammatory demyelinating polyneuropathy (CIDP). For painful DPN, pregabalin, capsaicin patch, and spinal cord electric stimulation were effective for pain relief. For CIPN, capsaicin patch and glutamine treatment showed possible beneficial effects. For ATTR amyloidosis, post–hoc analysis of the pivotal tafimidis trial revealed that the drug significantly delayed neuropathy progression, whereas a protocol paper for siRNA therapy was published. For POEMS syndrome, GBS, and CIDP, a novel treatment for each disorder finished or is on–going. These results showed sustained research activity to develop new therapies for a number of peripheral nerve disorders.

著者関連情報
© 2018 日本神経治療学会
前の記事 次の記事
feedback
Top